Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Mephedrone ("bath salt") pharmacology: insights from invertebrates.

Ramoz L, Lodi S, Bhatt P, Reitz AB, Tallarida C, Tallarida RJ, Raffa RB, Rawls SM.

Neuroscience. 2012 Apr 19;208:79-84. doi: 10.1016/j.neuroscience.2012.01.019. Epub 2012 Jan 20.

PMID:
22300981
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Mephedrone ('bath salt') elicits conditioned place preference and dopamine-sensitive motor activation.

Lisek R, Xu W, Yuvasheva E, Chiu YT, Reitz AB, Liu-Chen LY, Rawls SM.

Drug Alcohol Depend. 2012 Nov 1;126(1-2):257-62. doi: 10.1016/j.drugalcdep.2012.04.021. Epub 2012 May 29.

PMID:
22652295
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Mephedrone (4-methylmethcathinone), a principal constituent of psychoactive bath salts, produces behavioral sensitization in rats.

Gregg RA, Tallarida CS, Reitz A, McCurdy C, Rawls SM.

Drug Alcohol Depend. 2013 Dec 1;133(2):746-50. doi: 10.1016/j.drugalcdep.2013.06.014. Epub 2013 Jul 23.

PMID:
23890492
[PubMed - indexed for MEDLINE]
4.

First evidence that drugs of abuse produce behavioral sensitization and cross sensitization in planarians.

Rawls SM, Patil T, Yuvasheva E, Raffa RB.

Behav Pharmacol. 2010 Jul;21(4):301-13. doi: 10.1097/FBP.0b013e32833b0098.

PMID:
20512030
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter.

Cameron KN, Kolanos R, Solis E Jr, Glennon RA, De Felice LJ.

Br J Pharmacol. 2013 Apr;168(7):1750-7. doi: 10.1111/bph.12061.

PMID:
23170765
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Nicotine behavioral pharmacology: clues from planarians.

Rawls SM, Patil T, Tallarida CS, Baron S, Kim M, Song K, Ward S, Raffa RB.

Drug Alcohol Depend. 2011 Nov 1;118(2-3):274-9. doi: 10.1016/j.drugalcdep.2011.04.001. Epub 2011 May 6.

PMID:
21530106
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Behavioral pharmacology of designer cathinones: a review of the preclinical literature.

Gregg RA, Rawls SM.

Life Sci. 2014 Feb 27;97(1):27-30. doi: 10.1016/j.lfs.2013.10.033. Epub 2013 Nov 11. Review.

PMID:
24231450
[PubMed - indexed for MEDLINE]
8.

Rewarding properties of methylphenidate: sensitization by prior exposure to the drug and effects of dopamine D1- and D2-receptor antagonists.

Meririnne E, Kankaanpää A, Seppälä T.

J Pharmacol Exp Ther. 2001 Aug;298(2):539-50.

PMID:
11454915
[PubMed - indexed for MEDLINE]
Free Article
9.

Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum.

Angoa-Pérez M, Kane MJ, Francescutti DM, Sykes KE, Shah MM, Mohammed AM, Thomas DM, Kuhn DM.

J Neurochem. 2012 Mar;120(6):1097-107. doi: 10.1111/j.1471-4159.2011.07632.x. Epub 2012 Feb 9.

PMID:
22191803
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Comparison of the behavioral and cardiovascular effects of mephedrone with other drugs of abuse in rats.

Varner KJ, Daigle K, Weed PF, Lewis PB, Mahne SE, Sankaranarayanan A, Winsauer PJ.

Psychopharmacology (Berl). 2013 Feb;225(3):675-85. doi: 10.1007/s00213-012-2855-1. Epub 2012 Sep 13.

PMID:
22972412
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Parthenolide prevents the expression of cocaine-induced withdrawal behavior in planarians.

Rowlands AL, Pagán OR.

Eur J Pharmacol. 2008 Mar 31;583(1):170-2. doi: 10.1016/j.ejphar.2008.01.012. Epub 2008 Jan 26.

PMID:
18275955
[PubMed - indexed for MEDLINE]
12.

Withdrawal-like behavior in planarians is dependent on drug exposure duration.

Sacavage S, Patel H, Zielinski M, Acker J, Phillips AG, Raffa RB, Rawls SM.

Neurosci Lett. 2008 Jul 4;439(1):84-8. doi: 10.1016/j.neulet.2008.04.086. Epub 2008 Apr 30.

PMID:
18511196
[PubMed - indexed for MEDLINE]
13.

Nociceptin attenuates methamphetamine abstinence-induced withdrawal-like behavior in planarians.

Rawls SM, Baron S, Ding Z, Roth C, Zaveri N, Raffa RB.

Neuropeptides. 2008 Jun;42(3):229-37. doi: 10.1016/j.npep.2008.03.005. Epub 2008 May 13.

PMID:
18479746
[PubMed - indexed for MEDLINE]
14.

5-HT(1A)-like receptor activation inhibits abstinence-induced methamphetamine withdrawal in planarians.

Rawls SM, Shah H, Ayoub G, Raffa RB.

Neurosci Lett. 2010 Oct 29;484(2):113-7. doi: 10.1016/j.neulet.2010.08.027. Epub 2010 Aug 13.

PMID:
20709144
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

[Mephedrone: a new synthetic drug].

Petit A, Karila L, Sananes M, Lejoyeux M.

Presse Med. 2013 Oct;42(10):1310-6. doi: 10.1016/j.lpm.2012.11.019. Epub 2013 May 10. Review. French.

PMID:
23669315
[PubMed - indexed for MEDLINE]
16.

Reinforcing effects of methamphetamine in planarians.

Kusayama T, Watanabe S.

Neuroreport. 2000 Aug 3;11(11):2511-3.

PMID:
10943713
[PubMed - indexed for MEDLINE]
17.

4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse.

Hadlock GC, Webb KM, McFadden LM, Chu PW, Ellis JD, Allen SC, Andrenyak DM, Vieira-Brock PL, German CL, Conrad KM, Hoonakker AJ, Gibb JW, Wilkins DG, Hanson GR, Fleckenstein AE.

J Pharmacol Exp Ther. 2011 Nov;339(2):530-6. doi: 10.1124/jpet.111.184119. Epub 2011 Aug 2.

PMID:
21810934
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone.

López-Arnau R, Martínez-Clemente J, Pubill D, Escubedo E, Camarasa J.

Br J Pharmacol. 2012 Sep;167(2):407-20. doi: 10.1111/j.1476-5381.2012.01998.x.

PMID:
22509960
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Substitutional potential of mephedrone: an analysis of the subjective effects.

Kapitány-Fövény M, Kertész M, Winstock A, Deluca P, Corazza O, Farkas J, Zacher G, Urbán R, Demetrovics Z.

Hum Psychopharmacol. 2013 Jul;28(4):308-16. doi: 10.1002/hup.2297.

PMID:
23881878
[PubMed - indexed for MEDLINE]
20.

Prenatal and neonatal exposure to bisphenol-A enhances the central dopamine D1 receptor-mediated action in mice: enhancement of the methamphetamine-induced abuse state.

Suzuki T, Mizuo K, Nakazawa H, Funae Y, Fushiki S, Fukushima S, Shirai T, Narita M.

Neuroscience. 2003;117(3):639-44.

PMID:
12617968
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk